# Silo Pharma, Inc.: Form 8-K, filed Oct 24, 2025

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2025-10-24
- Accepted by EDGAR: Oct 24, 2025, 16:39 ET
- Period: 2025-10-24
- Accession: 0001213900-25-102222
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390025102222/ea0262461-8k_silopharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390025102222/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390025102222/ea0262461-8k_silopharma.htm

Filed Oct 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-102222. Last ingested by Listed: Nov 6, 2026, 18:16 ET. No prices; not investment advice.